Tick Insights

Search Icon

Menu Toggle Icon

Skip to content
  • Home
  • Forex
  • CFD Indices
  • CFD Equities
  • Education
  • Events
Tick Insights

Tag: Eli Lilly and Co

CFD Trading – Buy Eli Lilly & Co (LLY.NYS) @ $324.00. Stop @ $312.00 and Target @ $347.00.

June 27, 2022June 27, 2022Nicholas

Eli Lilly & Co Stock Code LLY.NYS

Outlook

Price broke and closed above a previous 52-week high in the previous trading session.… Read More

CFD Equities CFD US Trading Note, Eli Lilly and Co Leave a comment

CFD Trading – Buy Eli Lilly And Co (LLY.NYS) @ $193.30. Stop @ $192.90 and Target @ $211.80.

May 24, 2021May 24, 2021Nicholas
Eli Lily And Co Stock Code LLY.NYS

Outlook
Price moved above the cloud two days ago and this could signal the end of a price correction and the resumption of an uptrend for the previous high.… Read More

CFD Equities CFD US Trading Note, Eli Lilly and Co Leave a comment

CFD Trading – Buy Eli Lilly And Co (LLY.NYS) @ $147.90. Stop @ $142.70 and Target @ $155.90

December 7, 2020December 7, 2020Nicholas
Eli Lilly and Company Stock Code LLY.NYS

Outlook
Price broke above the cloud three days ago and could be moving higher.… Read More

CFD Equities CFD USD Trading Note, Eli Lilly and Co, LLY Leave a comment

About Us

Tick Insights

UTRADE

Upcoming Webinar

US & HK ETF Available For CFD Trade

Stay Connected

Subscribe to this blog and receive notifications of new posts by email.

Like our Facebook page for the latest updates!

 SG UTRADE

Recent Posts

  • CFD Trading – Buy PayPal Holdings Inc. (PYPL.NAS) @ $95.30. Stop @ $87.50 and Target @ $123.20.
  • CFD Trading – Sell Western Digital (WDC.NAS) @ $47.10. Stop @ $49.80 and Target @ $41.80.
  • FX Commentary – U.S. Dollar Remained On Tenterhooks Ahead Of NFP
  • CFD Indices – Wall Street’s Main Indexes Ended Mixed Ahead Of NFP
  • FX Commentary – Sterling Flat Ahead Of BOE Monetary Policy Meeting

Archives

Disclaimer

This information is prepared by personnel in UOB Kay Hian’s Alternative Products Department and is not the product of UOB Kay Hian’s Research Department. It is not a research report and is not intended as such, although a UOB Kay Hian Research report may be referenced as a link or as an attachment hereto.

Opinions expressed herein may differ from the opinions expressed by other areas of UOB Kay Hian, including research. This commentary is provided for information only. Neither the information nor any views expressed constitutes a solicitation for the purchase or sale of any securities or other financial instruments. It is not a personal recommendation, offer or solicitation to buy or sell.

Scroll to Top
 

Loading Comments...